- Home
- AKAN vs HSDT Comparison
AKAN vs HSDT Comparison
Compare AKAN & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKAN
- HSDT
- Stock Information
- Founded
- AKAN 2021
- HSDT 2014
- Country
- AKAN United Kingdom
- HSDT United States
- Employees
- AKAN N/A
- HSDT N/A
- Industry
- AKAN Medicinal Chemicals and Botanical Products
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AKAN Health Care
- HSDT Health Care
- Exchange
- AKAN Nasdaq
- HSDT Nasdaq
- Market Cap
- AKAN 2.4M
- HSDT 2.5M
- IPO Year
- AKAN 2022
- HSDT N/A
- Fundamental
- Price
- AKAN $1.32
- HSDT $0.49
- Analyst Decision
- AKAN
- HSDT Buy
- Analyst Count
- AKAN 0
- HSDT 2
- Target Price
- AKAN N/A
- HSDT $24.00
- AVG Volume (30 Days)
- AKAN 121.9K
- HSDT 236.6K
- Earning Date
- AKAN 01-04-2025
- HSDT 11-12-2024
- Dividend Yield
- AKAN N/A
- HSDT N/A
- EPS Growth
- AKAN N/A
- HSDT N/A
- EPS
- AKAN N/A
- HSDT N/A
- Revenue
- AKAN $2,508,317.00
- HSDT $502,000.00
- Revenue This Year
- AKAN N/A
- HSDT N/A
- Revenue Next Year
- AKAN N/A
- HSDT $8.97
- P/E Ratio
- AKAN N/A
- HSDT N/A
- Revenue Growth
- AKAN N/A
- HSDT N/A
- 52 Week Low
- AKAN $1.22
- HSDT $0.37
- 52 Week High
- AKAN $56.80
- HSDT $9.50
- Technical
- Relative Strength Index (RSI)
- AKAN 37.50
- HSDT 44.03
- Support Level
- AKAN $1.46
- HSDT $0.43
- Resistance Level
- AKAN $1.59
- HSDT $0.76
- Average True Range (ATR)
- AKAN 0.17
- HSDT 0.08
- MACD
- AKAN -0.02
- HSDT -0.01
- Stochastic Oscillator
- AKAN 5.71
- HSDT 17.91
About AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The Company has three reportable segments: Cultivation, Distribution, and Corporate. Cultivating activities comprise the cultivation segment made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.